Clinical Trials
2 trialsNCT00675545 2012-04-02
A Phase II Study of Docetaxel Plus Carboplatin in Chemonaive Hormone-Refractory Prostate Cancer (HRPC) Patients
National University Hospital, Singapore
Phase 2 Completed
NCT01133704 2010-09-08
Immunotherapy With APC8015 (Sipuleucel-T, Provenge) for Asymptomatic, Metastatic, Hormone-Refractory Prostate Cancer
Dendreon
Phase 3 Completed